Metabolic response of the CWR22 prostate tumor xenograft after 20 Gy of radiation studied by 1H spectroscopic imaging

Clinical Cancer Research

Volumn 9, Issue 12, 2003, Pages 4529-4536

  Dyke, Jonathan P ^a   Zakian, Kristen L ^b   Spees, William M ^b   Matei, Cornelia ^b   Chen, Yuchen ^b   Mao, Xiangling ^c   Shungu, Dikoma C ^c   Koutcher, Jason A ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; PROSTATE SPECIFIC ANTIGEN; WATER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER STAGING; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFICACY; HUMAN; HUMAN CELL; MALE; MATHEMATICAL ANALYSIS; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE TUMOR; RADIATION DOSE FRACTIONATION; SPECTROSCOPY; STATISTICAL SIGNIFICANCE; TUMOR VOLUME; XENOGRAFT;

ANIMALS; CHOLINE; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; NEOPLASMS, HORMONE-DEPENDENT; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS;

EID: 0141925954     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. American Cancer Society, Inc. Cancer Facts and Figures. New York: American Cancer Society, 2002.
2. Evelhoch, J. L., Gillies, R. J., Karczmar, G. S., Koutcher, J. A., et al. Applications of magnetic resonance in model systems: cancer therapeutics. Neoplasia, 2: 152-165, 2000.
3. Pretlow, T., Wolman, S., Micale, M., Pelley, R., Kursh, E., Resnick, M., Bodner, D., Jacobberger, C., Delmaro, C., Giacona, J., and Pretlow, T. Xenografts of primary human prostatic carcinoma. J. Natl. Cancer Inst., 85: 394-398, 1993.
4. Wainstein, M. A., He, F., Robinson, D., Kung, H. J., et al. CWR22: androgen-dependent xenograft model derived from a primary human prostatic carcinoma. Cancer Res., 54: 6049-6052, 1994.
5. Nagabhushan, M., Miller, C. M., Pretlow, T. P., Giaconia, J. M., et al. CWR22: the first human prostate cancer xenograft with strongly androgen- dependent and relapsed strains both in vivo and in soft agar. Cancer Res., 56: 3042-3046, 1996.
6. Zelefsky, M. J., Cohen, G., Zakian, K. L., Dyke, J., et al. Intraoperative conformal optimization for transperineal prostate implantation using magnetic resonance spectroscopic imaging. Cancer J., 6: 249-255, 2000.
7. Zaider, M., Zelefsky, M. J., Lee, E. K., Zakian, K. L., et al. Treatment planning for prostate implants using magnetic-resonance spectroscopy imaging. Int. J. Radiat. Oncol. Biol. Phys., 47: 1085-1096, 2000.
8. Zelefsky, M. J., Fuks, Z., Hunt, M., Lee, H. J., et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J. Urol., 166: 876-881, 2001.
9. Zietman, A. L., Westgeest, J. C., and Shipley, W. U. Radiation-based approaches to the management of T3 prostate cancer. Semin. Urol. Oncol., 15: 230-238, 1997.
10. 1H magnetic resonance spectroscopy and biochemical study. Magn. Reson. Med., 29: 149-157, 1993.
11. Aboagye, E. O., and Bhujwalla, Z. M. Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. Cancer Res., 59: 80-84, 1999.
12. Ackerstaff, E., Pflug, B. R., Nelson; J. B., and Bhujwalla, Z. M. Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells. Cancer Res., 61: 3599-3603, 2001.
13. Smith, T. A., Eccles, S., Ormerod, M. G., Tombs, A. J., et al. The phosphocholine and glycerophosphocholine content of an oestrogensensitive rat mammary tumour correlates strongly with growth rate. Br. J. Cancer, 64: 821- 826, 1991.
14. Rand, S. D., Prost, R., and Li, S. J. Proton MR spectroscopy of the brain. Neuroimaging Clin. North Am., 9: 379-395, 1999.
15. 3) spatial resolution. Radiology, 198: 795-805, 1996.
16. Kaji, Y., Kurhanewicz, J., Hricak, H., Sokolov, D., Huang, L., Nelson, S., and Vigneron, D. Localizing prostate cancer in the prescence of postbiopsy changes on MR images: role of proton MR spectroscopic images. Radiology, 206: 785-790, 1998.
17. 31P NMR spectroscopy. NMR Biomed., 8: 149-158, 1995.
18. Ballon, D., Mahmood, U., Jakubowski, A., and Koutcher, J. A. Resolution enhanced NMR spectroscopy in biological systems via magnetic susceptibility matched sample immersion chambers. Magn. Reson. Med., 30: 754-758, 1993.
19. 1H NMR spectroscopy. Magn. Reson. Med., 32: 277-284, 1994.
20. 1H NMR. Magn. Reson. Med., 25: 140-147, 1992.
21. Cornel, E. B., Smits, G. A., de Ruijter, J. E., Oosterhof, G. O., et al. In vitro proton magnetic resonance spectroscopy of four human prostate cancer cell lines. Prostate, 26: 275-280, 1995.
22. Yacoe, M. E., Sommer, G., and Peehl, D. In vitro proton spectroscopy of normal and abnormal prostate. Magn. Reson. Med., 19: 429-438, 1991.
23. 1H-spectroscopy of the human prostate: benign prostatic hyperplasia, normal peripheral zone and adenocarcinoma. Magn. Reson. Med., 29: 285-291, 1993.
24. 13C resonances. Biochim. Biophys. Acta, 805: 104-116, 1984.
25. Wald, L. L., Nelson, S. J., Day, M. R., Noworolski, S. E., et al. Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy. J. Neurosurg., 87: 525-534, 1997.
26. Tzika, A. A., Zurakowski, D., Poussaint, T. Y., Goumnerova, L., et al. Proton magnetic spectroscopic imaging of the child's brain: the response of tumors to treatment. Neuroradiology, 43: 169-177, 2001,
27. Koutcher, J. A., Alfieri, A. A., Devitt, M. L., Rhee, J. G., et al. Quantitative changes in tumor metabolism, partial pressure of oxygen, and radiobiological oxygenation status postradiation. Cancer Res., 52: 4620-4627, 1997.
28. 31P nuclear magnetic resonance spectroscopy. Cancer Res., 50: 7252-7256, 1990.
29. Bhujwalla, Z. M., and Glickson, J. D. Detection of tumor response to radiation therapy by in vivo proton MR spectroscopy. Int. J. Radiat. Oncol. Biol. Phys., 36: 635-639, 1996.
30. 1H nuclear magnetic resonance spectroscopy index for noninvasive prediction and early detection of tumor response to radiation therapy in EMT6 tumors. Radiat Res. 150: 38-42, 1998.
31. 1H nuclear magnetic resonance spectroscopy in vivo. Int. J. Radiat. Oncol. Biol. Phys., 33: 719-724, 1995.
32. Esteve, F., Rubin, C., Grand, S., Kolodie, H., et al. Transient metabolic changes observed with proton MR spectroscopy in normal human brain after radiation therapy. Int. J. Radiat. Oncol. Biol. Phys., 40: 279-286, 1998.
33. Agus, D. B., Golde, D. W., Sgouros, G., Ballangrud, A., et al. Positron emission tomography of a human prostate cancer xenograft: association of changes in deoxyglucose accumulation with other measures of outcome following androgen withdrawal. Cancer Res., 58: 3009-3014, 1998.
34. Kim, D., Gregory, C. W., French, F. S., Smith, G. J., et al. Androgen receptor expression and cellular proliferation during transition from androgen-dependent to recurrent growth after castration in the CWR22 prostate cancer xenograft. Am. J. Pathol., 160: 219-226, 2002.
35. Ross, G. M. Induction of cell death by radiotherapy. Endocr. Relat. Cancer, 6: 41-44, 1999.
36. Kim, D., Gregory, C. W., French, F. S., Smith, G. J., et al. Androgen receptor expression and cellular proliferation during transition from androgen-dependent to recurrent growth after castration in the CWR22 prostate cancer xenograft. Am. J. Pathol., 160: 219-226, 2002.
37. Zagars, G. K., Sherman, N. E., and Babaian, R. J. Prostate-specific antigen and external beam radiation therapy in prostate cancer. Cancer (Phila.), 67: 412-420, 1991.
38. Zakian, K. L., Koutcher, J. A., Ballon, D., Hricak, H., et al. Developments in nuclear magnetic resonance imaging and spectroscopy: application to radiation oncology. Semin. Radiat. Oncol., 11: 3-15, 2001.